|
|
|
0 members (),
3,019
guests, and
25
robots. |
|
Key:
Admin,
Global Mod,
Mod
|
|
S |
M |
T |
W |
T |
F |
S |
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
|
8
|
9
|
10
|
11
|
12
|
13
|
14
|
|
15
|
16
|
17
|
18
|
19
|
20
|
21
|
|
22
|
23
|
24
|
25
|
26
|
27
|
28
|
|
There are no members with birthdays on this day. |
#406999
Wed 07 Dec 2016 02:29:PM
|
Joined: Feb 2001
Posts: 381,904
Launch Director
|
OP
Launch Director
Joined: Feb 2001
Posts: 381,904 |
Alzheimer's disease affects more than 35 million people, a number that is expected to increase in the coming years. Currently, Alzheimer's diagnoses rely on clinical neuropathologic assessment of amyloid-beta peptide aggregates (plaques) and neurofibrillary tangles. But now researchers reveal that an enzyme already implicated in a host of neural disorders could someday serve as a biomarker. Source: MAO is a possible Alzheimer's disease biomarker
David Cottle
UBB Owner & Administrator
|
|
CMS The Best Conveyancing solicitors conveyancing quotes throughout the UK
For any webhosting enquiries please email webmaster@aus-city.com
|
|
Forums60
Topics759,926
Posts794,646
Members2,958
| |
Most Online17,963
Jan 15th, 2026
|
|
|
|
|
Copyright 1996 - 2026 by David Cottle. Designed by David Bate Jr. All Rights Reserved.
By using this forum, the user agrees not to transfer any data or technical information received under the agreement, to any other entity without the express approval of the AUS-CITY Forum Admins and/or authors of individual posts (Forum Admins and DoD/USSPACECOM for the analysis of satellite tracking data).
Two-line elements (TLE) and all other satellite data presented and distributed via this forum and e-mail lists of AUS-CITY are distributed with permission from DoD/USSTRATCOM.
Reprise Hosting
|
|
